NM_001753.5:c.195+13091G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001753.5(CAV1):c.195+13091G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0776 in 152,136 control chromosomes in the GnomAD database, including 638 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.078 ( 638 hom., cov: 32)
Consequence
CAV1
NM_001753.5 intron
NM_001753.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.17
Publications
37 publications found
Genes affected
CAV1 (HGNC:1527): (caveolin 1) The scaffolding protein encoded by this gene is the main component of the caveolae plasma membranes found in most cell types. The protein links integrin subunits to the tyrosine kinase FYN, an initiating step in coupling integrins to the Ras-ERK pathway and promoting cell cycle progression. The gene is a tumor suppressor gene candidate and a negative regulator of the Ras-p42/44 mitogen-activated kinase cascade. Caveolin 1 and caveolin 2 are located next to each other on chromosome 7 and express colocalizing proteins that form a stable hetero-oligomeric complex. Mutations in this gene have been associated with Berardinelli-Seip congenital lipodystrophy. Alternatively spliced transcripts encode alpha and beta isoforms of caveolin 1.[provided by RefSeq, Mar 2010]
CAV1 Gene-Disease associations (from GenCC):
- pulmonary arterial hypertensionInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- partial lipodystrophy, congenital cataracts, and neurodegeneration syndromeInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- pulmonary hypertension, primary, 3Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- congenital generalized lipodystrophy type 3Inheritance: AD, AR Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, G2P
- heritable pulmonary arterial hypertensionInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Berardinelli-Seip congenital lipodystrophyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- amyotrophic lateral sclerosisInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.156 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CAV1 | NM_001753.5 | c.195+13091G>A | intron_variant | Intron 2 of 2 | ENST00000341049.7 | NP_001744.2 | ||
| CAV1 | NM_001172895.1 | c.102+13091G>A | intron_variant | Intron 2 of 2 | NP_001166366.1 | |||
| CAV1 | NM_001172896.2 | c.102+13091G>A | intron_variant | Intron 1 of 1 | NP_001166367.1 | |||
| CAV1 | NM_001172897.2 | c.102+13091G>A | intron_variant | Intron 2 of 2 | NP_001166368.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0776 AC: 11804AN: 152018Hom.: 638 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
11804
AN:
152018
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0776 AC: 11806AN: 152136Hom.: 638 Cov.: 32 AF XY: 0.0831 AC XY: 6183AN XY: 74384 show subpopulations
GnomAD4 genome
AF:
AC:
11806
AN:
152136
Hom.:
Cov.:
32
AF XY:
AC XY:
6183
AN XY:
74384
show subpopulations
African (AFR)
AF:
AC:
2055
AN:
41510
American (AMR)
AF:
AC:
1295
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
115
AN:
3472
East Asian (EAS)
AF:
AC:
853
AN:
5164
South Asian (SAS)
AF:
AC:
567
AN:
4816
European-Finnish (FIN)
AF:
AC:
1851
AN:
10578
Middle Eastern (MID)
AF:
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4918
AN:
67990
Other (OTH)
AF:
AC:
124
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
544
1089
1633
2178
2722
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
138
276
414
552
690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
392
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.